HEADER HORMONE 29-DEC-12 2M2P TITLE STRUCTURE OF [D-HISB24] INSULIN ANALOGUE AT PH 8.0 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN A CHAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: INSULIN B CHAIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 SYNTHETIC: YES; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606 KEYWDS INSULIN, HORMONE EXPDTA SOLUTION NMR NUMMDL 30 AUTHOR L.ZAKOVA,V.VEVERKA,J.JIRACEK REVDAT 2 05-JUN-13 2M2P 1 JRNL REVDAT 1 06-MAR-13 2M2P 0 JRNL AUTH E.KLETVIKOVA,V.VEVERKA,M.LEPSIK,C.J.WATSON,J.P.TURKENBURG, JRNL AUTH 2 J.JIRACEK,A.M.BRZOZOWSKI JRNL TITL STRUCTURAL INTEGRITY OF THE B24 SITE IN HUMAN INSULIN IS JRNL TITL 2 IMPORTANT FOR HORMONE FUNCTIONALITY. JRNL REF J.BIOL.CHEM. V. 288 10230 2013 JRNL REFN ISSN 0021-9258 JRNL PMID 23447530 JRNL DOI 10.1074/JBC.M112.448050 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : AMBER REMARK 3 AUTHORS : CASE, DARDEN, CHEATHAM, III, SIMMERLING, WANG, REMARK 3 DUKE, LUO, KOLLMAN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2M2P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-JAN-13. REMARK 100 THE RCSB ID CODE IS RCSB103133. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 8.0 REMARK 210 IONIC STRENGTH : 0.025 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.250 MM CHAIN_A, 0.250 MM REMARK 210 CHAIN_B, 25 MM [U-2H] TRIS, 95% REMARK 210 H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D 1H-1H NOESY; REMARK 210 2D DQF-COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 30 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 3 CYS A 6 CB - CA - C ANGL. DEV. = 7.4 DEGREES REMARK 500 4 ARG B 22 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 16 ARG B 22 NE - CZ - NH1 ANGL. DEV. = 4.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLN A 5 -12.45 57.60 REMARK 500 1 CYS A 6 -108.40 56.49 REMARK 500 1 CYS A 7 18.26 55.14 REMARK 500 1 THR A 8 -61.70 -90.90 REMARK 500 1 VAL B 2 -45.17 -133.76 REMARK 500 1 CYS B 7 138.41 64.13 REMARK 500 1 SER B 9 -168.05 -122.68 REMARK 500 1 HIS B 10 -28.64 61.43 REMARK 500 1 DHI B 24 -53.50 145.77 REMARK 500 1 PHE B 25 -161.90 52.05 REMARK 500 2 CYS A 7 -70.92 52.80 REMARK 500 3 CYS A 6 45.11 -80.40 REMARK 500 3 THR A 8 -50.20 65.31 REMARK 500 3 HIS B 5 162.15 65.74 REMARK 500 4 CYS A 7 153.85 65.72 REMARK 500 4 GLN B 4 156.10 64.04 REMARK 500 4 SER B 9 -25.49 61.48 REMARK 500 4 DHI B 24 -40.87 79.26 REMARK 500 4 TYR B 26 103.79 54.48 REMARK 500 5 GLN A 5 44.48 -78.13 REMARK 500 5 ILE A 10 94.16 47.37 REMARK 500 5 VAL B 2 -54.85 54.62 REMARK 500 5 LEU B 6 46.94 -79.46 REMARK 500 5 TYR B 26 98.72 55.22 REMARK 500 6 GLN A 5 54.43 -142.15 REMARK 500 6 CYS A 6 19.70 55.63 REMARK 500 6 ASN B 3 -146.64 55.39 REMARK 500 6 CYS B 7 -98.35 -147.05 REMARK 500 6 HIS B 10 -27.92 60.37 REMARK 500 6 GLU B 21 171.72 58.79 REMARK 500 7 GLN B 4 174.30 61.14 REMARK 500 8 ARG B 22 33.27 -89.82 REMARK 500 9 CYS A 7 148.24 56.03 REMARK 500 9 SER A 9 -149.69 -103.58 REMARK 500 9 SER A 12 167.82 59.64 REMARK 500 9 DHI B 24 -142.35 -60.67 REMARK 500 11 VAL A 3 -25.02 67.29 REMARK 500 11 GLN A 5 -52.95 59.53 REMARK 500 11 CYS A 7 -40.54 -167.50 REMARK 500 11 LEU A 13 -42.37 62.92 REMARK 500 12 THR A 8 -35.65 64.22 REMARK 500 12 GLN B 4 -179.63 -69.74 REMARK 500 12 CYS B 7 -45.73 -22.74 REMARK 500 13 CYS A 6 42.20 -86.65 REMARK 500 13 THR A 8 -47.08 60.45 REMARK 500 13 VAL B 2 -47.68 64.06 REMARK 500 13 CYS B 19 -32.26 -141.74 REMARK 500 13 LYS B 29 136.98 64.99 REMARK 500 14 CYS A 11 146.74 61.25 REMARK 500 14 VAL B 2 -19.96 55.34 REMARK 500 REMARK 500 THIS ENTRY HAS 133 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 DHI B 24 PHE B 25 10 144.91 REMARK 500 HIS B 5 LEU B 6 19 -149.68 REMARK 500 THR A 8 SER A 9 27 -148.37 REMARK 500 ARG B 22 GLY B 23 29 147.98 REMARK 500 ARG B 22 GLY B 23 30 147.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 1 TYR A 19 0.10 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 15 VAL A 3 24.9 L L OUTSIDE RANGE REMARK 500 24 VAL B 2 24.8 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DHI B 24 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 18925 RELATED DB: BMRB REMARK 900 RELATED ID: 2M2N RELATED DB: PDB REMARK 900 RELATED ID: 2M2O RELATED DB: PDB REMARK 900 RELATED ID: 2M2M RELATED DB: PDB DBREF 2M2P A 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 2M2P B 1 30 UNP P01308 INS_HUMAN 25 54 SEQADV 2M2P DHI B 24 UNP P01308 PHE 48 ENGINEERED MUTATION SEQRES 1 A 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 A 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 B 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 B 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY DHI PHE TYR SEQRES 3 B 30 THR PRO LYS THR HET DHI B 24 17 HETNAM DHI D-HISTIDINE FORMUL 2 DHI C6 H10 N3 O2 1+ HELIX 1 1 SER A 12 ASN A 21 1 10 HELIX 2 2 HIS B 10 CYS B 19 1 10 SSBOND 1 CYS A 6 CYS A 11 1555 1555 2.04 SSBOND 2 CYS A 7 CYS B 7 1555 1555 2.04 SSBOND 3 CYS A 20 CYS B 19 1555 1555 2.03 LINK C GLY B 23 N DHI B 24 1555 1555 1.34 LINK C DHI B 24 N PHE B 25 1555 1555 1.34 CISPEP 1 GLN B 4 HIS B 5 1 -13.30 CISPEP 2 CYS B 7 GLY B 8 1 -6.73 CISPEP 3 GLN A 5 CYS A 6 2 -9.48 CISPEP 4 PHE B 1 VAL B 2 2 -0.15 CISPEP 5 PRO B 28 LYS B 29 2 0.01 CISPEP 6 CYS A 7 THR A 8 4 -9.73 CISPEP 7 THR A 8 SER A 9 4 -1.01 CISPEP 8 THR A 8 SER A 9 5 -1.48 CISPEP 9 GLY A 1 ILE A 2 6 1.50 CISPEP 10 PHE B 1 VAL B 2 6 -6.20 CISPEP 11 GLN B 4 HIS B 5 6 10.27 CISPEP 12 VAL B 2 ASN B 3 7 -13.00 CISPEP 13 GLU B 21 ARG B 22 7 -3.34 CISPEP 14 ARG B 22 GLY B 23 7 -1.86 CISPEP 15 GLY B 8 SER B 9 8 -5.59 CISPEP 16 PRO B 28 LYS B 29 8 -10.37 CISPEP 17 CYS A 7 THR A 8 9 -6.65 CISPEP 18 THR A 8 SER A 9 9 2.48 CISPEP 19 GLU B 21 ARG B 22 9 -6.74 CISPEP 20 DHI B 24 PHE B 25 9 -6.07 CISPEP 21 GLY B 23 DHI B 24 10 0.23 CISPEP 22 TYR B 26 THR B 27 11 1.71 CISPEP 23 GLY A 1 ILE A 2 12 4.74 CISPEP 24 ASN B 3 GLN B 4 12 -0.13 CISPEP 25 GLY B 20 GLU B 21 12 1.04 CISPEP 26 PRO B 28 LYS B 29 12 -12.85 CISPEP 27 CYS A 6 CYS A 7 14 -7.66 CISPEP 28 GLY B 20 GLU B 21 14 1.46 CISPEP 29 PRO B 28 LYS B 29 14 3.18 CISPEP 30 GLY A 1 ILE A 2 15 1.50 CISPEP 31 CYS B 19 GLY B 20 15 9.34 CISPEP 32 CYS A 6 CYS A 7 16 -0.26 CISPEP 33 PHE B 25 TYR B 26 17 -12.67 CISPEP 34 VAL A 3 GLU A 4 19 -6.04 CISPEP 35 ASN B 3 GLN B 4 19 -1.47 CISPEP 36 GLN B 4 HIS B 5 19 -0.98 CISPEP 37 GLY A 1 ILE A 2 22 -0.78 CISPEP 38 CYS B 7 GLY B 8 22 -7.37 CISPEP 39 ASN B 3 GLN B 4 24 -8.42 CISPEP 40 GLY B 23 DHI B 24 24 -2.46 CISPEP 41 GLN B 4 HIS B 5 25 8.65 CISPEP 42 GLY B 20 GLU B 21 25 5.57 CISPEP 43 GLY B 20 GLU B 21 27 6.62 CISPEP 44 VAL B 2 ASN B 3 28 -5.77 CISPEP 45 GLN A 5 CYS A 6 29 5.36 CISPEP 46 CYS B 19 GLY B 20 29 -0.63 SITE 1 AC1 4 TYR B 16 CYS B 19 GLY B 23 PHE B 25 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 220 0 1 2 0 0 1 6 0 0 0 5 END